These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4078814)

  • 1. Estrogen use and cardiovascular disease.
    Henderson BE; Ross RK; Paganini-Hill A
    J Reprod Med; 1985 Oct; 30(10 Suppl):814-20. PubMed ID: 4078814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estrogen replacement therapy on lipids. Implications for cardiovascular risk.
    LaRosa JC
    J Reprod Med; 1985 Oct; 30(10 Suppl):811-3. PubMed ID: 4078813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy. Effect on blood pressure and other cardiovascular risk factors.
    Kaplan NM
    J Reprod Med; 1985 Oct; 30(10 Suppl):802-4. PubMed ID: 4078812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen replacement therapy. Measuring benefit v cardiovascular risk.
    Mishell DR
    J Reprod Med; 1985 Oct; 30(10 Suppl):795-6. PubMed ID: 4078810
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of progestagens in estrogen replacement therapy].
    Teter J; Potocki J
    Ginekol Pol; 1979; Suppl():286-7. PubMed ID: 548404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen use and cardiovascular disease.
    Henderson BE; Ross RK; Paganini-Hill A; Mack TM
    Am J Obstet Gynecol; 1986 Jun; 154(6):1181-6. PubMed ID: 3717228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral hormone therapy in the pre- and postmenopausal period].
    Braendle W; Bettendorf G
    Gynakologe; 1986 Dec; 19(4):235-40. PubMed ID: 3817595
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thoughts on long-term estrogen substitution--should gynecologists change their mind?].
    Völker W; Hesch RD; Schneider HP
    Geburtshilfe Frauenheilkd; 1985 May; 45(5):326-32. PubMed ID: 3924723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is estrogen replacement therapy necessary?
    Hammond CB; Nachtigall LE
    J Reprod Med; 1985 Oct; 30(10 Suppl):797-801. PubMed ID: 4078811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of cardiovascular diseases by hormone replacement in postmenopause].
    Windler E
    Zentralbl Gynakol; 1996; 118(4):188-97. PubMed ID: 8651005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New preparations for treatment of climacterial disorders].
    Nesheim BI
    Tidsskr Nor Laegeforen; 1979 May; 99(15):792-3. PubMed ID: 462446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New viewpoints in the treatment of postmenopausal complaints].
    Lauritzen C
    Arch Gynecol Obstet; 1987; 242(1-4):471-9. PubMed ID: 3688962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormone therapy and the risk of cancer in the climacteric].
    Kuhl H; Taubert HD
    Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cost-benefit-risk analysis of estrogen treatment in the climacteric].
    Lauritzen C
    Gynakologe; 1986 Dec; 19(4):266-75. PubMed ID: 3102324
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.
    Heckbert SR; Weiss NS; Koepsell TD; Lemaitre RN; Smith NL; Siscovick DS; Lin D; Psaty BM
    Arch Intern Med; 1997 Jun; 157(12):1330-6. PubMed ID: 9201007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The climacteric and its hormonal treatment].
    Gvorgiev DB
    Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.